Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

Celebrate the Annual Celebrity Steak-Out! Join us for an evening of food, fun and philanthropy at Celebrity Steak-Out presented by Brotherton Cadillac Buick GMC. A silent auction and cocktail hour ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

Pain Clinic Services Cancer pain care needs to be carefully coordinated. It requires careful follow-up of issues and medications that can complicate a patient’s overall care. Cancer pain changes ...

Patient provider profile for Dr. Michael Schweizer, medical oncologist at Fred Hutchinson Cancer Center.

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...